Cita APA (7a ed.)

K, K., N, O., M, F., & M, F. (2019). Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion. Dove Medical Press.

Cita Chicago Style (17a ed.)

K, Kumagai, Ogino N, Fukami M, y Furukawa M. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.

Cita MLA (8a ed.)

K, Kumagai, et al. Long-term Outcomes of Intravitreous Bevacizumab or Tissue Plasminogen Activator or Vitrectomy for Macular Edema Due to Branch Retinal Vein Occlusion. Dove Medical Press, 2019.